November 22, 2011
A retrospective analysis of serum samples from the phase III study, EGF30008, will be presented at the 34th Annual San Antonio Breast Cancer Symposium SABCS.
A leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease.
2970 Wilderness Place, Suite 100 Boulder, CO 80301
© Copyright 2021 Biodesix. All Rights Reserved.